41results about How to "Significant selectivity" patented technology

Catalytic compositions useful for carrying out the metathesis of unsaturated fatty bodies, in particular unsaturated fatty bodies comprising oleic acid or oleic acid esters, contain a ruthenium-based catalyst which can be isolated and which has the formula (I) below:

The present invention discloses mixed matrix membranes (MMMs) comprising a polymer matrix and molecular sieve particles and methods for making and using these membranes. The molecular sieve particles contain micropores or mesopores and exhibit a thin plate morphology with high aspect ratio and the plate thickness no more than 300 nm. This invention also pertains to controlling the alignment of the thin plate molecular sieve particles in the continuous polymer matrix of the thin dense selective layer of the asymmetric mixed matrix membranes. These MMMs exhibited much higher selectivity improvement than those comprising molecular sieve particles with other kinds of morphology for gas separations such as CO₂/CH₄ and H₂/CH₄ separations. The thin plate morphology of molecular sieves is beneficial to make high performance mixed matrix membranes. The MMMs are suitable for a variety of liquid, gas, and vapor separations

The invention discloses an optimization method for a track playback function in an indoor positioning system, wherein the optimization method comprises the following steps of: S1, importing an indoor CAD (Computer-Aided Design) map into a monitoring center of the indoor positioning system; S2, acquiring the boundary, the scale and the coordinates of obstacles of the imported current map by the monitoring center automatically; S3, identifying the obstacles by the monitoring center, formatting the current map area and optimizing the specification scenery color of the map; S4, recording and storing the track coordinate data of the electronic tag movement, carried by a positioned object, by the monitoring center via a communication network; S5, optimizing the recorded track data by the monitoring center by adopting an A* algorithm and recording optimal obstacle avoidance data; and S6, drawing the track point and the trajectory by the monitoring center according to the optimized track data. Compared with the prior art, the invention has the advantages of greatly improving the performance of track playback, and has the obvious optimal choice of a track path and an intelligent obstacle avoidance function.

A metal oxide film suitable for protection of metals, composed mainly of aluminum. A metal oxide film includes a film of an oxide of a metal composed mainly of aluminum, having a thickness of 10 nm or greater, and exhibiting a moisture release rate from the film of 1E18 mol./cm² or less. Further, there is provided a process for producing a metal oxide film, wherein a metal composed mainly of aluminum is subjected to anodic oxidation in a chemical solution of 4 to 10 pH value so as to obtain a metal oxide film.

A system for transmitting and receiving medical vital signs from a “smart” vital sign apparatus over multi-protocol communication channels to and from a remote electronic health record database that may include a plurality of vital sign sources that communicate over a plurality of standard communication channels including: Bluetooth, LoRa, WiFi, cellular, Ethernet or other direct IP paths. The system reduces the volume of data transferred and extends BLE security.

The invention belongs to the technical field of medicines and provides an oleanolic acid-3-one derivative which is represented as the following general formula. In the general formula, R is defined as the specification. The invention also relates to the preparation method of the compounds and potential applications of the compounds as antitumor medicines.

The invention discloses a molecular imprinting polymer filter paper for absorbing penicillin. The filter paper is prepared by following steps: (1) dissolving penicillin and monomer in acetonitrile, sealing, standing still for at least 6 hours, adding an initiator and a cross-linking agent, introducing nitrogen to remove the oxygen in the solution; (2) putting a filter paper into the solution prepared in the step (1), oscillating for at least 3 hours, taking the filter paper out, putting the filter paper in a dry container, sealing the container, putting the container in a constant temperature incubator with a temperature of 50 to 80 DEG C, and having polymerization reaction for 8 to 24 hours; (3) putting the filter paper prepared in the step (2) into a mixed solution of methanol and acetic acid, oscillating, washing away the penicillin, non-polymerized monomers and cross-linking agent on the filter paper, soaking the filter paper in methanol, washing away acetic acid, and drying so as to obtain the molecular imprinting polymer filter paper for absorbing penicillin. The monomer is a mixture of itaconic acid, acrylamide and 2-vinylpyridine with a mol ratio of 1:1 to 1.5:0.5 to 1, and the cross-linking agent is pentaerythritol tetramethacrylate. The molecular imprinting polymer filter paper for absorbing penicillin is a cheap and high-efficient antibiotic absorption material.

A polymer article having structure (I), where P comprises the basic polymer and groups -L-CH(-X(R1)p)-CH2(-Y(R2)p); L is a part of a pending group utilized for introducing -X(R1)p and -Y(R2)p; X and Y are halogen, N, S and O; R1 is hydrogen, alkyl, acyl or R2 when X is N, O or S; R2 is hydrogen, alkyl, alkylaryl or arylalkyl in which the alkyl part may contain 1-18 carbons, or -R3(-NH-CR4=O)q or -R3(-NH2)q, -CR4=O or poly alkyloxy that may have been terminally acylated or alkylated; p is an integer 0-3, with the provisos a) p depends on X being halogen, O, S or N, and b) that if several groups R2 are present they may be identical or different; R3 is alkyl, -O-alkyl, hydroxyalkyl, phenylalkyl, with up to 18 carbon atoms in the alkyl part, and R4 is C1-18 alkyl. q is an integer>O representing that one or more hydrogens in R3 may have been replaced with -NH2 or -NH-CR4=O. The polymer article may be used as a chromatography separation medium or in solide phase oligonucleotide synthesis.

Compounds of formula (I) are inhibitors of LMP7 and can be employed, inter alia, for the treatment of an autoimmune disorder or hematological malignancies.

This invention encompasses synthetic antimicrobial peptide analogs having certain un-natural amino acids, including the un-natural amino acids hydrophobic tetrahydroisoquinolinecarboxylic acid (Tic) and octahydroindolecarboxylic acid (Oic), incorporated into the polypeptide backbone. These antimicrobial peptides (AMPs) are useful to treat infection in humans and other mammals of such bacteria as Gram positive bacteria, Gram negative bacteria and Mycobacterium. Many of the AMPs also exhibit the property of reduced hemolytic activity. The invention also entails 3D-QSAR models and mathematical equations that calculate the biological activity of any peptide sequence against Staphylococcus aureus or Mycobacterium ranae.

The present invention relates to a process for production of oligomer products from olefinic C4 feed stocks comprising isobutene, butenes, butanes, butadienes and mixture thereof. Particularly, the present invention relates to a process for the preparation of oligomers using olefinic C4 feed stock in presence of tertiary butyl alcohol (TBA) and iso propyl alcohol (IPA).

The present invention provides novel spiro[cyclobutane-1,3′-indolin]-2′-one derivatives of formula (I)

in which Cy, R₁, R₂, R₄, L, and m have the meaning given in the specification, and pharmaceutically acceptable salts thereof. The compounds of formula (I) are useful as bromodomain inhibitors in the treatment or prevention of diseases or disorders where bromodomain inhibition is desired.

The present invention relates to a process for improving the selectivity of an EO process utilizing a highly selective EO catalyst. In particular, the present invention is an improvement in the initial operation of a process for manufacturing ethylene oxide by contacting ethylene, oxygen, a chloride moderator and a hydrocarbon co-moderator with a high selectivity silver-containing catalyst at a concentration of carbon dioxide of less than about 2 mole percent, wherein the initial operating temperature is determined by optimization of such initial operating temperature at a level higher than the normal low initial operating temperature that is typically selected to obtain a longer operating cycle.